Our updated combined analysis of data from SOFT and TEXT showed that after a median follow up of 9 years, treatment with exemestane plus ovarian suppression resulted in sustained and consistently higher rates of disease free survival and freedom from distant recurrence than the rates with tamoxifen plus ovarian suppression
priligy dapoxetine 5 83 and median OS varying between 9